MedPath

FORTUNE NATIONAL (HONG KONG) LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

PPB:23

Drug Approvals

NORMODIN TABLETS 5MG

Approval Date
Nov 2, 2017
PPB

TG TOLNAF CREAM 10MG/G

Approval Date
Oct 9, 2017
PPB

NIFUROXAZIDE CAPSULES 200MG

Approval Date
Oct 31, 2016
PPB

BACTERIX CAPSULES 200MG

Approval Date
Oct 31, 2016
PPB

ARTHROLOC GLUCOSAMINE SULFATE POWDER FOR ORAL SOLUTION 1.5G

Approval Date
Sep 9, 2015
PPB

ALLERVID OPH. EYE DROPS 0.1%W/V

Approval Date
Nov 18, 2014
PPB

LISATRIAM (TRIAMCINOLONE ACETONIDE) SUSPENSION FOR INJECTION 40MG/1ML

Approval Date
Aug 28, 2014
PPB

NIBERAN TABLETS 100MG

Approval Date
Aug 28, 2014
PPB

STOMACHAL TAB 150MG

Approval Date
Dec 23, 2011
PPB

DICLO-ACHE PATCH 60MG/PATCH

Approval Date
Dec 30, 2009
PPB
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.